UPLC/MS/MS Method for the Quantification of Trastuzumab in Human Serum at the 5-nM Level Using Xevo TQD MS and ACQUITY UPLC H-Class System
12 Jun 2013

This application note addresses some critical challenges in the world of bioanalysis, such as developing a method to quantify protein molecules with desired sensitivity in a robust, reproducible, high-throughput LC/MS/MS system.

It demonstrates the capability of Xevo® TQD to conduct bioanalysis of large protein molecules, such as trastuzumab, a monoclonal antibody. Oasis® micro-elution plates, the ACQUITY UPLC® H-Class System, and an advanced tandem quadrupole mass spectrometer (Xevo TQD) were used for the development of a sensitive method for the quantification of trastuzumab in human serum digest.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!